retatrutide triple Unapproved weight loss drug causes extreme side effects Retatrutide - “Triple G” |
Description
Between 2021 and 2024, global sales of Ozempic surged from US$5.3bn to US$18.9bn, while Wegovy amassed global sales of US$9.2bn
Regular monitoring of body composition, waist circumference, and metabolic parameters provides a more comprehensive assessment of treatment success than weight alone
HSD17B13, hydroxysteroid 17-beta dehydrogenase 13
Visit our Endocrinology Department at Continental Hospitals, Hyderabad, for expert evaluation, advanced care, and personalized treatment from our specialists
Fatigue Some patients experience fatigue, particularly during dose titration
